CARISOPRODOL | N012155 | SCHERING CORP SUB SCHERING PLOUGH CORP
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Citizen Petition A from Biopharmaceutics, Inc. FDA-1988-P-0040 Biopharmaceutics, Inc. filed this citizen petition under 21 U.S.C. Section 505(j)(2)(A) and (C) requesting that the FDA find the combination drug Carisoprodol 200mg and Acetaminophen 325mg suitable for abbreviated new drug application approval, arguing that Acetaminophen can substitute for Aspirin i | Other | 2017-06-28 | Withdrawn | — |
Citizen Petition B from Biopharmaceutics, Inc. FDA-1988-P-0040 Biopharmaceutics, Inc. filed this citizen petition on June 17, 1988, under 21 U.S.C. Section 505(j)(2)(A) and (C), requesting that the FDA find a combination drug product containing Carisoprodol 200 mg and Acetaminophen 325 mg suitable for approval as an Abbreviated New Drug Application. The petitio | 505(q) | 2017-06-28 | Withdrawn | — |
Source: Regulations.gov. FDA citizen petitions matched by application number.
No patent or exclusivity listings for this strength.